Nasal Drug Delivery Technology Market Analysis Report By Therapeutic Application (Asthma, Rhinitis), By Dosage Form (Powder, Gel, Spray, Drops), By Container Type, And Segment Forecasts, 2019 - 2025

Published: Jan, 2019 | Pages: 90 | Publisher: Grand View Research
Industry: Pharmaceutical | Report Format: Electronic (PDF)

The global nasal drug delivery systems market size is expected to reach USD 67.99 billion by 2025 expanding at 6.5% CAGR, according to a new report by Grand View Research, Inc. Rising awareness about nasal products is one of the major factors driving the market. Growing geriatric population is also expected to have positive impact on the market. According to the United Nations Department of Economic and Social Affairs, the global geriatric population (60 years and above), was around 962 million in 2017. The number is expected to grow, particularly in Latin America with 71% rise in population aged 60 and over, followed by Asia (66%), Africa (64%), North America (41%), and Europe (23%).

Moreover, ongoing product development and their expected commercialization will propel market growth over the forecast period. For instance, In April 2018, Dr. Reddy's Laboratories, along with its subsidiary Promius Pharma, LLC, announced filing of their New Drug Application (NDA) for DFN-02, for the treatment of migraine. Increasing adoption of self-administration practices and focus on other alternative routes of drug delivery, such as nasal drug delivery, also offer growth opportunities for the market. Some of the key companies in the industry are AstraZeneca PLC; OptiNose, Inc.; Pfizer, Inc.; Becton, Dickinson and Company; Promius Pharma LLC; B.F. Ascher & Company, Inc.; and Cadila Pharmaceuticals Ltd.

Further key findings from the study suggest :

• Nasal sprays led the dosage type segment in 2017 due to increased prevalence of asthma and other infectious diseases

• On the other hand, nasal drops segment witnessed the fastest growth in 2017 owing to availability of cost-effective products with better efficacy

• Non-pressurized containers segment led the market in 2017 due to continous development in nasal powders and gel products

• Asthma was the dominant therapeutic application segment in 2017 and is estimated to be the fastest-growing segment with a CAGR of 7.0% during the forecast years due to increasing disease prevalence

• Geographically, North America held the largest share in 2017. Asia Pacific is estimated to witness the fastest CAGR of 7.5% due to presence of key companies, such as Cipla Inc.

• Some of the leading companies in the global nasal drug delivery technology market are GlaxoSmithKline PLC; AstraZeneca PLC; Pfizer, Inc.; OptiNose, Inc.; Becton, Dickinson and Company; Promius Pharma, LLC; Cadila Pharmaceuticals Ltd.; B.F. Ascher & Company, Inc.; PendoPharm, Inc.; Douglas Pharmaceuticals Ltd.; ENT Technologies Pty. Ltd.; and NAVEH Pharma Ltd.

 Table of Contents

Chapter 1 Methodology and Scope
                   1.1 Research Methodology
                   1.2 Research Scope and Assumptions
                   1.3 List of Tables

Chapter 2 Executive Summary
                   2.1 Market Summary

Chapter 3 Market Variables, Trends & Scope
                   3.1 Market Segmentation

Chapter 4 Market Definitions

Chapter 5 Industry Outlook
                   5.1 Market Variable Analysis
                       5.1.1 Increasing preference for nasal drug delivery technology
                       5.1.2 Growing incidence of chronic diseases
                       5.1.3 Growing geriatric population
                   5.2 Market Restraint Analysis
                       5.2.1 Complications associated with the overuse of nasal powders

Chapter 6 Business Environment Analysis
                   6.1 SWOT Analysis; By factor (Political & legal, economic and technological)
                   6.2 Porter's Five Forces Analysis

Chapter 7 Dosage Forms Business Analysis
                   7.1 Nasal Drug Delivery Technology market: Dosage Forms Movement Analysis
                   7.2 Nasal Spray
                       7.2.1 Nasal sprays market estimates and forecast, 2014 - 2025
                   7.3 Nasal Drop
                       7.3.1 Nasal drops market estimates and forecast, 2014 - 2025
                   7.4 Nasal Gel
                       7.4.1 Nasal gels market estimates and forecast, 2014 - 2025
                   7.5 Nasal Powder
                       7.5.1 Nasal powder market estimates and forecast, 2014 - 2025

Chapter 8 Container Type Business Analysis
                   8.1 Nasal Drug Delivery Technology market: Container Type Movement Analysis
                   8.2 Pressurized container
                   8.3 Pressurized container market estimates and forecast, 2014 - 2025
                   8.4 Non-pressurized container
                   8.5 Non-pressurized container market estimates and forecast, 2014 - 2025

Chapter 9 Therapeutic Application Business Analysis
                   9.1 Nasal Drug Delivery Technology market: Therapeutic Application Movement Analysis
                   9.2 Nasal Congestion
                       9.2.1 Nasal congestion market estimates and forecast, 2014 - 2025
                   9.3 Rhinitis
                       9.3.1 Rhinitis market estimates and forecast, 2014 - 2025
                   9.4 Asthma
                       9.4.1 Asthma market estimates and forecast, 2014 - 2025
                   9.5 Others
                       9.5.1 Others market estimates and forecast, 2014 - 2025

Chapter 10 Regional Business Analysis
                   10.1 Nasal Drug Delivery Technology Market: Regional Movement Analysis
                   10.2 North America.
                       10.2.1 North America market estimates and forecast, 2014 - 2025
                       10.2.2 U.S.
                           10.2.2.1 U.S. market estimates and forecast, 2014 - 2025
                       10.2.3 Canada
                           10.2.3.1 Canada market estimates and forecast, 2014 - 2025
                   10.3 Europe
                       10.3.1 Europe market estimates and forecast, 2014 - 2025
                       10.3.2 Germany
                       10.3.3 Germany market estimates and forecast, 2014 - 2025
                       10.3.4 U.K.
                       10.3.5 U.K. market estimates and forecast, 2014 - 2025
                   10.4 Asia-Pacific
                       10.4.1 Asia-Pacific market estimates and forecast, 2014 - 2025
                       10.4.2 Japan
                           10.4.2.1 Japan market estimates and forecast, 2014 - 2025
                       10.4.3 China
                           10.4.3.1 China market estimates and forecast, 2014 - 2025
                       10.4.4 India
                           10.4.4.1 India market estimates and forecast, 2014 - 2025
                   10.5 Latin America
                       10.5.1 Latin America market estimates and forecast, 2014 - 2025
                       10.5.2 Brazil
                           10.5.2.1 Brazil market estimates and forecast, 2014 - 2025
                       10.5.3 Mexico
                           10.5.3.1 Market estimates and forecast, 2014 - 2025
                   10.6 Middle East and Africa
                       10.6.1 Middle-East and Africa market estimates and forecast, 2014 - 2025
                       10.6.2 South Africa
                       10.6.3 South Africa market estimates and forecast, 2014 - 2025

Chapter 11 Company Profiles
                   11.1 Company Profiles
                       11.1.1 GlaxoSmithkline plc.
                           11.1.1.1 Company overview
                           11.1.1.2 Financial Performance
                           11.1.1.3 Product benchmarking
                           11.1.1.4 Strategic initiatives
                       11.1.2 AstraZeneca
                           11.1.2.1 Company overview
                           11.1.2.2 Financial performance
                           11.1.2.3 Product benchmarking
                           11.1.2.4 Strategic initiatives
                       11.1.3 Pfizer, Inc.
                           11.1.3.1 Company overview
                           11.1.3.2 Financial performance
                           11.1.3.3 Product benchmarking
                       11.1.4 OptiNose
                           11.1.4.1 Company overview
                           11.1.4.2 Product benchmarking
                           11.1.4.3 Strategic initiatives
                       11.1.5 Becton, Dickson and Company 
                           11.1.5.1 Company overview
                           11.1.5.2 FINANCIAL PERFORMANCE
                           11.1.5.3 Product benchmarking
                       11.1.6 Promius Pharma
                           11.1.6.1 Company overview
                           11.1.6.2 FINANCIAL PERFORMANCE
                           11.1.6.3 Product Benchmarking
                           11.1.6.4 strategic initiatives
                       11.1.7 B.F. Ascher & Company, Inc.
                           11.1.7.1 Company overview
                           11.1.7.2 Product benchmarking
                       11.1.8 Cadila Pharmaceuticals
                           11.1.8.1 Company overview
                           11.1.8.2 Financial performance
                           11.1.8.3 Product Benchmarking
                       11.1.9 Douglas NZ
                           11.1.9.1 Company overview
                           11.1.9.2 Product benchmarking
                       11.1.10 ENT Technologies Pty. Ltd.
                           11.1.10.1 Company Overview
                           11.1.10.2 Product Benchmarking
                       11.1.11 Pendopharm
                           11.1.11.1 Company Overview
                           11.1.11.2 Product Benchmarking
                       11.1.12 NAVEH Pharma
                           11.1.12.1 Company Overview
                           11.1.12.2 Product Benchmarking

List of Tables

Table 1 List of Abbreviation
Table 2 North America Nasal Drug Delivery Technology market, by dosage form 2014 - 2025 (USD Billion)
Table 3 North America Nasal Drug Delivery Technology market, by container type 2014 - 2025 (USD Billion)
Table 4 North America Nasal Drug Delivery Technology market, by therapeutic application 2014 - 2025 (USD Billion)
Table 5 U.S. Nasal Drug Delivery Technology market, by dosage types 2014 - 2025 (USD Billion)
Table 6 U.S. Nasal Drug Delivery Technology market, by container type 2014 - 2025 (USD Billion)
Table 7 U.S. Nasal Drug Delivery Technology market, by therapeutic applications 2014 - 2025 (USD Billion)
Table 8 Canada Nasal Drug Delivery Technology market, by dosage forms 2014 - 2025 (USD Billion)
Table 9 Canada Nasal Drug Delivery Technology market, by container type 2014 - 2025 (USD Billion)
Table 10 Canada Nasal Drug Delivery Technology market, by therapeutic applications 2014 - 2025 (USD Billion)
Table 11 Europe Nasal Drug Delivery Technology market, by dosage forms 2014 - 2025 (USD Billion)
Table 12 Europe Nasal Drug Delivery Technology market, by container type 2014 - 2025 (USD Billion)
Table 13 Europe Nasal Drug Delivery Technology market, by therapeutic applications 2014 - 2025 (USD Billion)
Table 14 Germany Nasal Drug Delivery Technology market, by dosage forms 2014 - 2025 (USD Billion)
Table 15 Germany Nasal Drug Delivery Technology market, by container type 2014 - 2025 (USD Billion)
Table 16 Germany Nasal Drug Delivery Technology market, by therapeutic application 2014 - 2025 (USD Billion)
Table 17 U.K. Nasal Drug Delivery Technology market, by dosage forms 2014 - 2025 (USD Billion)
Table 18 U.K. Nasal Drug Delivery Technology market, by container type 2014 - 2025 (USD Billion)
Table 19 U.K. Nasal Drug Delivery Technology market, by therapeutic application 2014 - 2025 (USD Billion)
Table 20 Asia Pacific Nasal Drug Delivery Technology market, by dosage forms 2014 - 2025 (USD Billion)
Table 21 Asia Pacific Nasal Drug Delivery Technology market, by container type 2014 - 2025 (USD Billion)
Table 22 Asia Pacific Nasal Drug Delivery Technology market, by therapeutic applications 2014 - 2025 (USD Billion)
Table 23 Japan Nasal Drug Delivery Technology market, by dosage forms 2014 - 2025 (USD Billion)
Table 24 Japan Nasal Drug Delivery Technology market, by container type 2014 - 2025 (USD Billion)
Table 25 Japan Nasal Drug Delivery Technology market, by therapeutic applications 2014 - 2025 (USD Billion)
Table 26 China Nasal Drug Delivery Technology market, by dosage forms 2014 - 2025 (USD Billion)
Table 27 China Nasal Drug Delivery Technology market, by container type 2014 - 2025 (USD Billion)
Table 28 China Nasal Drug Delivery Technology market, by therapeutic applications 2014 - 2025 (USD Billion)
Table 29 India Nasal Drug Delivery Technology market, by dosage forms 2014 - 2025 (USD Billion)
Table 30 India Nasal Drug Delivery Technology market, by container type 2014 - 2025 (USD Billion)
Table 31 India Nasal Drug Delivery Technology market, by therapeutic applications 2014 - 2025 (USD Billion)
Table 32 Latin America Nasal Drug Delivery Technology market, by dosage forms 2014 - 2025 (USD Billion)
Table 33 Latin America Nasal Drug Delivery Technology market, by container type 2014 - 2025 (USD Billion)
Table 34 Latin America Nasal Drug Delivery Technology market, by distribution channel 2014 - 2025 (USD Billion)
Table 35 Brazil Nasal Drug Delivery Technology market, by dosage forms 2014 - 2025 (USD Billion)
Table 36 Brazil Nasal Drug Delivery Technology market, by container type 2014 - 2025 (USD Billion)
Table 37 Brazil Nasal Drug Delivery Technology market, by therapeutic applications 2014 - 2025 (USD Billion)
Table 38 Mexico Nasal Drug Delivery Technology market, by dosage forms 2014 - 2025 (USD Billion)
Table 39 Mexico Nasal Drug Delivery Technology market, by container type 2014 - 2025 (USD Billion)
Table 40 Mexico Nasal Drug Delivery Technology market, by therapeutic applications 2014 - 2025 (USD Billion)
Table 41 MEA Nasal Drug Delivery Technology market, by dosage forms 2014 - 2025 (USD Billion)
Table 42 MEA Nasal Drug Delivery Technology market, by container type 2014 - 2025 (USD Billion)
Table 43 MEA Nasal Drug Delivery Technology market, by therapeutic applications 2014 - 2025 (USD Billion)
Table 44 South Africa Nasal Drug Delivery Technology market, by dosage forms 2014 - 2025 (USD Billion)
Table 45 South Africa Nasal Drug Delivery Technology market, by container type 2014 - 2025 (USD Billion)
Table 46 South Africa Nasal Drug Delivery Technology market, by therapeutic applications 2014 - 2025 (USD Billion)

List of Figures

Fig.1 Nasal Drug Delivery Technology market, 2017
Fig.2 Nasal Drug Delivery Technology market segmentation
Fig.3 Nasal Drug Delivery Technology market driver impact
Fig.4 Nasal Drug Delivery Technology market driver impact
Fig.5 SWOT Analysis, By Factor (Political & legal Economic and technological)
Fig.6 Porter's Five Forces Analysis
Fig.7 Nasal Drug Delivery Technology market: Dosage form outlook and key takeaways
Fig.8 Nasal Drug Delivery Technology market: Dosage Form Movement Analysis
Fig.9 Nasal sprays market estimates and forecast, 2014 - 2025
Fig.10 Nasal drops market estimates and forecast, 2014 - 2025
Fig.11 Nasal gels market estimates and forecast, 2014 - 2025
Fig.12 Nasal powder market estimates and forecast, 2014 - 2025
Fig.13 Nasal Drug Delivery Technology market: Container type outlook and key takeaways
Fig.14 Nasal Drug Delivery Technology market: Container Type Movement Analysis
Fig.15 Pressurized containers market estimates and forecast, 2014 - 2025
Fig.16 Non-pressurized containers market estimates and forecast, 2014 - 2025
Fig.17 Nasal Drug Delivery Technology market: Therapeutic application outlook and key takeaways
Fig.18 Nasal Drug Delivery Technology market: Therapeutic Application Movement Analysis
Fig.19 Nasal congestion market estimates and forecast, 2014 - 2025
Fig.20 Rhinitis market estimates and forecast, 2014 - 2025
Fig.21 Asthma market estimates and forecast, 2014 - 2025
Fig.22 Others market estimates and forecast, 2014 - 2025
Fig.23 Nasal Drug Delivery Technology market: Regional outlook and key takeaways
Fig.24 Nasal Drug Delivery Technology market: Regional movement analysis
Fig.25 North America
Fig.26 North America. market estimates and forecast, 2014 - 2025
Fig.27 U.S. market estimates and forecast, 2014 - 2025
Fig.28 Canada market estimates and forecast, 2014 - 2025
Fig.29 Europe
Fig.30 Europe market estimates and forecast, 2014 - 2025
Fig.31 Germany market estimates and forecast, 2014 - 2025
Fig.32 U.K. market estimates and forecast, 2014 - 2025
Fig.33 Asia-Pacific
Fig.34 Asia-Pacific market estimates and forecast, 2014 - 2025
Fig.35 Japan market estimates and forecast, 2014 - 2025
Fig.36 China. market estimates and forecast, 2014 - 2025
Fig.37 India market estimates and forecast, 2014 - 2025
Fig.38 Latin America
Fig.39 Latin America market estimates and forecast, 2014 - 2025
Fig.40 Brazil market estimates and forecast, 2014 - 2025
Fig.41 Mexico market estimates and forecast, 2014 - 2025
Fig.42 Middle East & Africa
Fig.43 MEA market estimates and forecast, 2014 - 2025
Fig.44 South Africa market estimates and forecast, 2014 - 2025
Fig.45 Company profile